GVENLA Trademark

Trademark Overview


On Thursday, September 3, 2015, a trademark application was filed for GVENLA with the United States Patent and Trademark Office. The USPTO has given the GVENLA trademark a serial number of 86746241. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 22, 2019. This trademark is owned by Pfizer Inc.. The GVENLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
gvenla

General Information


Serial Number86746241
Word MarkGVENLA
Filing DateThursday, September 3, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 22, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 26, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 8, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, April 22, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 22, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, August 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 16, 2018EXTENSION 5 GRANTED
Wednesday, August 8, 2018EXTENSION 5 FILED
Thursday, August 16, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 8, 2018TEAS EXTENSION RECEIVED
Thursday, February 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 20, 2018EXTENSION 4 GRANTED
Tuesday, February 20, 2018EXTENSION 4 FILED
Tuesday, February 20, 2018TEAS EXTENSION RECEIVED
Saturday, July 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 20, 2017EXTENSION 3 GRANTED
Thursday, July 20, 2017EXTENSION 3 FILED
Thursday, July 20, 2017TEAS EXTENSION RECEIVED
Thursday, February 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2017EXTENSION 2 GRANTED
Tuesday, February 7, 2017EXTENSION 2 FILED
Tuesday, February 7, 2017TEAS EXTENSION RECEIVED
Friday, August 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 10, 2016EXTENSION 1 GRANTED
Wednesday, August 10, 2016EXTENSION 1 FILED
Wednesday, August 10, 2016TEAS EXTENSION RECEIVED
Tuesday, March 22, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 15, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 14, 2015ASSIGNED TO EXAMINER
Tuesday, September 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 7, 2015NEW APPLICATION ENTERED IN TRAM